Symbol="VTGN"
AssetType="Common Stock"
Name="VistaGen Therapeutics Inc"
Description="VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing and commercializing several drugs with the potential to treat anxiety, depression, and other central nervous system (CNS) disorders. The company is headquartered in South San Francisco, California."
CIK="1411685"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="March"
LatestQuarter="2023-03-31"
MarketCapitalization="13587900"
EBITDA="-59138500"
PERatio="None"
PEGRatio="0"
BookValue="1.652"
DividendPerShare="0"
DividendYield="0"
EPS="-10.16"
RevenuePerShareTTM="-0.033"
ProfitMargin="0"
OperatingMarginTTM="260.75"
ReturnOnAssetsTTM="-0.774"
ReturnOnEquityTTM="-1.543"
RevenueTTM="-227300"
GrossProfitTTM="-227300"
DilutedEPSTTM="-10.16"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="3.514"
AnalystTargetPrice="6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="23.15"
PriceToBookRatio="0.838"
EVToRevenue="44.96"
EVToEBITDA="0.131"
Beta="0.788"
num_52WeekHigh="32.1"
num_52WeekLow="1.62"
num_50DayMovingAverage="3.082"
num_200DayMovingAverage="4.121"
SharesOutstanding="7872500"
DividendDate="None"
ExDividendDate="None"
symbol="VTGN"
open="1.82"
high="1.82"
low="1.72"
price="1.77"
volume="104200.00"
latest_trading_day="2023-07-14"
previous_close="1.80"
change="-0.03"
change_percent="-1.6667%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="72"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="28"
Volume_recent_avg="3116362"
Change_recent_avg="-0.02"
Delta_recent_avg="0.07"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-2.32"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="28"
Aroon_momentum_negative="72"
image_negative_thumbnail_id_1="1125"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0158.jpeg"
image_negative_thumbnail_id_2="124"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0052.jpeg"
image_neutral_thumbnail_id_1="545"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_neutral_thumbnail_id_2="575"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0024.jpeg"
image_positive_thumbnail_id_1="694"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0014.jpeg"
image_positive_thumbnail_id_2="950"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0112.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1177"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
